About Us

Intervacc develop novel veterinary vaccines and the pipeline is based on new technology using recombinant proteins rather than attenuated live strains found in conventional vaccines. This results in vaccines with much lower incidence of side effects usually seen with conventional vaccines, something we take pride in as it greatly contributes to an improved animal welfare.